Mental Health Act Sections 2 & 3 — civil detention (ED overview)
MHA s2/s3 · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Section 2 permits detention for assessment (and treatment) for up to 28 days; section 3 permits detention for treatment for up to 6 months (renewable). Both require an AMHP (or nearest relative) application plus two medical recommendations, one from a s12-approved doctor. The ED clinician's role is to recognise the need, exclude organic disease and facilitate timely assessment.
Red flags
- Organic cause of disturbance not excluded
- Active suicidal or homicidal intent
- Physical illness requiring urgent treatment alongside mental disorder
- Pregnancy or other factors complicating medication choice
- Rapid behavioural escalation
Assessment
Differential diagnosis
- First-episode psychosis or relapse of chronic psychotic illness
- Acute mania / bipolar disorder
- Severe depression with suicidality
- Delirium or organic brain disorder mimicking mental illness
- Dementia with behavioural disturbance
Investigations
- Full organic screen: glucose, FBC, U&E, LFTs, CRP, calcium, TFTs
- Toxicology and alcohol level
- CT head if focal signs, first presentation at atypical age, or confusion
- ECG prior to any antipsychotic
- Mental state examination and risk assessment documented
Management
- Recognise mental disorder of a nature/degree warranting detention with risk to self/others or health
- Exclude and treat organic causes — a delirious patient needs medical, not MHA, management
- Contact AMHP to coordinate assessment and the two medical recommendations
- Provide a safe, low-stimulus environment and continuous observation per risk level
- Support the assessing doctors with collateral history and examination findings
- Facilitate transfer to an appropriate psychiatric bed once sectioned
- Document capacity, risk and the medical clearance clearly
Drugs & doses
Lorazepam — 1-2 mg PO/IM for agitation, repeat; max 4 mg/24h caution
Haloperidol — 5 mg IM (2.5 mg elderly) with prior ECG and benzodiazepine
Olanzapine — 10 mg IM (5 mg elderly); do not combine within 1 hour of parenteral benzodiazepine
Promethazine — 50 mg IM alternative sedative
Disposition
Facilitate AMHP-coordinated assessment for detention under s2 or s3 once organic causes are excluded, and arrange transfer to a psychiatric unit; patients not meeting criteria go to crisis/home treatment team follow-up.
Complications & pitfalls
- Detaining a patient with undiagnosed delirium
- Delayed bed availability prolonging ED stay
- Deterioration while awaiting assessment
- Medication interactions or over-sedation
- Dispute with nearest relative over s3 application
Exam pearls
- s2 is for assessment (28 days, not renewable); s3 is for treatment (6 months, renewable) and usually needs a known diagnosis
- Two medical recommendations are needed; at least one doctor must be s12-approved and ideally one should know the patient
- The MHA cannot be used to treat physical illness unrelated to the mental disorder
- ED medical clearance should be thorough but not obstruct timely psychiatric assessment
- Patients retain the right to appeal to a tribunal and to an independent mental health advocate
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.